- Home
- CLPT
as 06-20-2025 3:33pm EST
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SOLANA BEACH |
| Market Cap: | 376.2M | IPO Year: | N/A |
| Target Price: | $25.00 | AVG Volume (30 days): | 289.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.11 - $19.22 | Next Earning Date: | 08-06-2025 |
| Revenue: | $32,235,999 | Revenue Growth: | 23.22% |
| Revenue Growth (this year): | 23.97% | Revenue Growth (next year): | 27.52% |
Stock Insider Trading Activity of ClearPoint Neuro Inc. (CLPT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Richards Timothy T. | CLPT | Director | Jun 10 '25 | Sell | $13.28 | 10,000 | $132,800.00 | 77,381 | |
| BURNETT JOSEPH MICHAEL | CLPT | CEO and President | Jun 9 '25 | Sell | $13.29 | 21,247 | $282,372.63 | 243,522 | |
| FALLON LYNNETTE C | CLPT | Director | Jun 3 '25 | Sell | $12.71 | 10,200 | $128,226.00 | 42,101 |
Latest ClearPoint Neuro Inc. News
CLPT Breaking Stock News: Dive into CLPT Ticker-Specific Updates for Smart Investing
Insider Monkey
12 days ago
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory
TipRanks
18 days ago
Lake Street says AMT-130 could be ‘significantly impactful’ for ClearPoint
Simply Wall St.
a month ago
ClearPoint Neuro First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
a month ago
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
ACCESS Newswire
a month ago
ClearPoint Neuro Reports First Quarter 2025 Results
ACCESS Newswire
a month ago
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
GuruFocus.com
a month ago
ClearPoint Neuro Inc (CLPT) Q1 2025 Earnings Report Preview: What to Look For
ACCESS Newswire
2 months ago
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
Compare CLPT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CLPT ClearPoint Neuro Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.